cmecorner.com The Single Best Source of Free CME and CE Programs

Print this page

Program Title Recent Advances and Current Trends in Managing Pain: A Case-Based Approach Release Date: NaN/NaN/NaN Credit Expiration Date: NaN/NaN/NaN Medium CD ROM & Monograph Target Audience This educational activity has been designed for physcians and other healthcare practitioners with an interest in pain management. Program Description Older patients frequently have a need for pain medication for conditions such as osteoarthritis. Treating this population can be problematic because of comorbid disorders such as hypertension, diabetes mellitus, congestive heart failure, and previous or present gastropathies that require modification of the pain treatment regimen. Use of traditional NSAIDs has been associated with adverse effects related to the above mentioned comorbidities. This educational activity presents expert speakers who discuss pain management using COX-2 inhibitors and traditional NSAIDs. Additionally, case histories illustrating specfic examples of treatment strategies are provided. Learning Objectives Upon completion of this educational activity, the participant should be able to: 1. Review factors that influence the design of pain treatment strategies (e.g., extent of disease process, comorbidities). 2. Describe the place of COX-2 inhibitors in a multimodal pain treatment plan. 3. Identify appropriate monitoring strategies for the pain patient with renal impairment. 4. Explain how pain assessment scales can enhance effective pain management. Faculty Gary Ruoff, MD, Activity Chairman Clinical Professor of Family Medicine Michigan State University College of Medicine Kalamazoo, MI D. Craig Brater, MD Professor of Medicine, Department of Medicine Dean, Indiana University School of Medicine Indianapolis, IN Marc D. Cohen, MD Professor of Medicine Chairman, Division of Rheumatology Mayo Medical School Jacksonville, FL Raymond Sinatra, MD, PhD Professor of Anesthesiology Director of Pain Service Yale University School of Medicine New Haven, CT Disclosures Gary Ruoff, MD, has a financial interest/relationship or affiliation in the form of: Grant/Research Support from Elan Corporation, Merck & Co., Inc.; Pfizer Inc.; Pharmacia and Upjohn Company; and Ortho-McNeil Pharmaceuticals. Consultant for Elan Corporation; Merck & Co., Inc.; Pfizer Inc., Pharmacia and Upjohn Company; and Ortho-McNeil Pharmaceuticals. Speakers’ Bureau participant with Elan Corporation; Merck & Co., Inc.; Pfizer Inc.; Pharmacia and Upjohn Company; and Ortho-McNeil Pharmaceuticals. D. Craig Brater, MD, has a financial interest/relationship or affiliation in the form of: Consultant for AstraZeneca Pharmaceuticals; BioGen, Inc.; Forest Laboratories; Merck & Co., Inc.; Pfizer Inc.; and Pharmacia and Upjohn Company. Marc D. Cohen, MD, has a financial interest/relationship or affiliation in the form of: Consultant for Amgen, Inc.; Centocor; Immunex Corporation; Merck & Co., Inc.; Pfizer Inc.; and Wyeth Pharmaceuticals. Raymond Sinatra, MD, has a financial interest/relationship or affiliation in the form of: Grant/Research Support from Merck & Co., Inc. Speakers’ Bureau participant with Merck & Company. Credit Hours 4 Commercial Support Statements Made possible by an unrestricted educational grant from Merck & Co., Inc. Credit Statements The Postgraduate Institute for Medicine designates this educational activity for a maximum of 4.0 hour(s) in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Postgraduate Institute for Medicine and Medical Communication Media. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. Disclaimer The information contained in this program does not necessarily reflect the opinions or recommendations of the Postgraduate Institute for Medicine, Merck & Co., Inc., or Medical Communications Media, Inc. Diagnostic procedures or treatments discussed in the program should not be utilized by clinicians without evaluation of patients’ conditions and possible contraindications or risks, and without a review of applicable manufacturer’s product information and comparison with recommendations of other authorities.